Winona Pricing Analysis & Total Cost: What You Actually Pay for Telehealth HRT in 2026

How Winona's Pricing Model Works

Winona operates on a subscription model where the initial physician consultation is bundled into the monthly medication cost. Patients complete an online health assessment, receive a provider review (asynchronous in most cases), and are prescribed a hormone regimen shipped directly to their door. There is no separate office visit charge.

Monthly costs range from $89 for single-agent regimens (such as progesterone alone) to $199 or more for multi-hormone protocols combining estradiol cream, oral progesterone, and adjunct therapies like DHEA or low-dose testosterone. Shipping is included. The platform does not accept insurance, meaning the full cost is out-of-pocket.

This pricing sits within the typical range for direct-to-consumer telehealth HRT. A 2023 analysis by the Kaiser Family Foundation found that telehealth visits for chronic conditions averaged $73 per encounter when billed to insurance, but cash-pay models bundle visits differently, making direct comparisons difficult [1]. Winona's approach eliminates per-visit charges but locks patients into recurring monthly payments regardless of how often they interact with their provider.

One important distinction: Winona primarily dispenses compounded hormones through partner pharmacies rather than commercially manufactured FDA-approved products. The FDA has stated that compounded drugs "are not FDA-approved" and "do not undergo FDA premarket review for safety, effectiveness, or quality" [2]. This does not mean compounded hormones are inherently dangerous, but it does mean patients are paying a premium for products that lack the regulatory oversight applied to approved generics.

What Does Winona Actually Prescribe?

Winona's formulary centers on bioidentical hormone formulations. The most commonly prescribed agents include topical estradiol, oral micronized progesterone (similar to Prometrium), vaginal DHEA, and in some cases compounded testosterone cream.

The 2022 Hormone Therapy Position Statement from The North American Menopause Society (NAMS) recommends FDA-approved hormone therapy as first-line treatment for vasomotor symptoms, stating that "hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause" [3]. NAMS specifically notes that "custom-compounded bioidentical hormone therapies... have the same safety considerations as FDA-approved hormone therapies, with the additional concern of batch-to-batch variability" [3].

This is worth weighing. FDA-approved oral micronized progesterone (generic Prometrium) costs $15 to $30 per month at most pharmacies with a GoodRx coupon. Generic estradiol patches run $20 to $45 per month. A patient using both through a local pharmacy with a standard telehealth consultation ($50 to $75 per visit, typically every 3 to 6 months) could spend as little as $500 to $900 per year. That is less than half of what a comparable Winona subscription might cost annually.

The convenience factor is real, though. Winona handles prescribing, fulfillment, and ongoing monitoring in a single platform. For patients who have struggled to find a menopause-literate provider (a well-documented problem, given that a 2023 survey in Menopause found only 31.4% of OB-GYN residency programs provided any menopause curriculum [4]), the streamlined access has genuine value.

Is Winona Legit? Evaluating the Clinical Model

Winona is a licensed telehealth company operating across most U.S. states. It employs or contracts with licensed physicians and nurse practitioners who prescribe within state scope-of-practice regulations. The platform is not a scam.

The more useful question is whether the clinical model delivers appropriate care. The Endocrine Society's 2015 Clinical Practice Guideline on menopausal hormone therapy recommends individualized treatment based on symptom severity, time since menopause onset, and cardiovascular risk profile [5]. Personalization matters. The Women's Health Initiative (WHI) trial, which enrolled 27,347 postmenopausal women, demonstrated that the risk-benefit ratio of HRT varies substantially based on patient age and years since menopause [6]. Women who initiate HRT within 10 years of menopause onset show a more favorable cardiovascular profile than those starting later.

Asynchronous telehealth models (where patients fill out forms and receive prescriptions without a live video or phone consultation) raise questions about whether this level of individualization is possible. A 2021 study in JAMA Internal Medicine examining telehealth prescribing patterns found that asynchronous encounters were associated with higher prescribing rates for certain medications compared to synchronous visits [7]. The study's authors noted that "the absence of real-time dialogue may limit shared decision-making."

Winona does offer messaging with providers and follow-up consultations, so it is not purely asynchronous. Still, patients should expect to advocate for themselves. Ask about specific formulations. Request lab work if it has not been ordered. Confirm that your cardiovascular risk factors have been assessed.

Winona vs. Alternatives: Head-to-Head Cost Comparison

Several telehealth HRT platforms compete directly with Winona. Here is how pricing compares across the most established options.

Midi Health charges a $249 initial consultation fee with subsequent visits at $99 to $149. Midi prescribes FDA-approved hormones through commercial pharmacies, meaning patients can use insurance for medication costs. Total first-year cost for a patient on generic estradiol patches plus oral progesterone through Midi: approximately $600 to $1,200, including consultation fees and pharmacy copays.

Evernow uses a subscription model similar to Winona, with monthly costs ranging from $129 to $199 for compounded formulations. Annualized cost: $1,548 to $2,388.

Alloy Health charges $199 for an initial consultation and $49 for follow-ups, with medications billed separately through retail pharmacies. Annualized cost on generic HRT: approximately $700 to $1,100.

Traditional in-office care with an OB-GYN or endocrinologist typically involves a $150 to $350 office visit (or insurance copay of $20 to $60), with medications at pharmacy pricing. The American College of Obstetricians and Gynecologists (ACOG) recommends annual follow-up for women on HRT [8]. Annualized cost with insurance: $300 to $700 for most patients.

The pattern is clear. Winona's total cost is competitive with other subscription-based compounding platforms (Evernow in particular) but costs meaningfully more than models that route prescriptions through retail pharmacies where insurance or discount cards apply. The NAMS 2022 position statement explicitly states that "FDA-approved hormone therapy formulations are preferred over compounded preparations" when an equivalent product exists [3].

The Compounding Premium: What You're Paying For

A significant portion of Winona's pricing reflects the compounding markup. Compounded hormones bypass standard pharmaceutical distribution. They are mixed by specialty pharmacies, often to specific doses or delivery forms not commercially available (such as combination creams or custom-dosed troches).

The FDA's 2024 guidance on pharmacy compounding notes that compounding fills a legitimate need when a patient requires a formulation, dose, or dosage form that is not commercially available [2]. However, when an FDA-approved equivalent exists (and for estradiol and progesterone, it does), the compounded version offers no proven clinical advantage.

A 2020 analysis published in Menopause compared serum hormone levels in women using compounded versus FDA-approved transdermal estradiol and found "no significant difference in achieved serum estradiol concentrations" but noted "greater variability in serum levels with compounded preparations" [9]. Greater variability means less predictable dosing, which can affect both symptom control and safety monitoring.

Dr. Stephanie Faubion, director of the Mayo Clinic Center for Women's Health and medical director of NAMS, has stated: "There is no evidence that compounded bioidentical hormones are safer or more effective than FDA-approved versions. Patients deserve to know what they are paying for" [10].

So what are patients paying for? Convenience, primarily. And access. Winona removes friction from the prescribing process. That has value for the estimated 1.3 million American women who enter menopause each year [11], many of whom report difficulty finding knowledgeable providers.

Hidden Costs and What's Not Included

Winona's monthly subscription covers the provider consultation and medication fulfillment. It does not cover several things that standard HRT management typically requires.

Lab work is not included. Standard monitoring for women on HRT often involves baseline and follow-up labs including lipid panels, liver function tests, and in some cases serum hormone levels. The Endocrine Society recommends monitoring lipids and mammography per USPSTF guidelines for women on systemic HRT [5]. Lab costs vary from $50 to $200 per panel without insurance, or $0 to $30 with insurance.

Mammography and preventive screening is the patient's responsibility. The USPSTF recommends biennial screening mammography for women aged 50 to 74, and this recommendation does not change with HRT use [12]. Women on combined estrogen-progesterone therapy should be aware that the WHI found a small but statistically significant increase in breast cancer incidence (HR 1.24 to 95% CI 1.01 to 1.54) after a median 5.6 years of use [6].

Bone density screening may also be relevant, as estrogen therapy has documented bone-protective effects. The WHI showed a 34% reduction in hip fractures (HR 0.66 to 95% CI 0.45 to 0.98) among women on conjugated equine estrogen plus medroxyprogesterone acetate [6]. Patients who start HRT partly for bone protection should have baseline DEXA scans, which Winona does not arrange.

Factoring in external labs and preventive care adds $200 to $500 per year to the true cost of a Winona regimen.

When Winona Might Make Sense (and When It Doesn't)

Winona is a reasonable option for a specific patient profile: women who cannot find a local menopause-literate provider, who are paying cash for healthcare (uninsured or underinsured), and who value the convenience of an all-in-one subscription. For this group, Winona's $89 to $199 monthly price may actually represent savings over repeated out-of-pocket specialist visits at $250 to $400 each.

Winona is a poor value proposition for women who have insurance with pharmacy benefits, access to a knowledgeable local provider, or a preference for FDA-approved formulations. These patients can obtain the same active ingredients (estradiol, micronized progesterone) for a fraction of Winona's cost.

The 2017 NAMS position statement noted that approximately 6,000 women per day reach menopause in the United States [3]. According to a 2019 analysis in JAMA, only 12.6% of menopausal women who could benefit from HRT actually receive it [13]. Cost and access barriers contribute to this gap. Telehealth platforms like Winona address the access problem but may worsen the cost problem for some patients.

The most cost-effective approach for most women: use a telehealth platform that prescribes FDA-approved generics fillable at your local pharmacy, use GoodRx or insurance for the medication itself, and reserve compounded hormones for cases where no commercial equivalent exists.

How to Evaluate Whether You're Overpaying

Before committing to any telehealth HRT subscription, run this five-point check.

Check your insurance formulary. Generic estradiol patches and oral micronized progesterone are on most formularies at Tier 1 or Tier 2 pricing. If your copay is $10 to $30 per month, a $150-plus subscription for the same active ingredients is overspending.

Price-check at a retail pharmacy. Use GoodRx or CostPlus Drugs. Estradiol patches (0.05 mg/day, 8 patches): roughly $25 to $40 without insurance. Progesterone 100 mg capsules (30-count): roughly $15 to $25. Combined: under $65 per month.

Ask about the specific formulation. If a telehealth platform prescribes a compounded product and an FDA-approved version of the same hormone at the same dose exists, ask why. There should be a clinical reason (allergy to an inactive ingredient, need for a non-standard dose, combination not commercially available).

Factor in all costs. Add lab work, screening, and any out-of-network fees to the subscription price before comparing.

Assess your access. If you live in a rural area or a state with few menopause specialists, the premium for a platform like Winona may be justified by the access it provides. The ACOG workforce analysis has documented significant geographic disparities in OB-GYN availability, with some counties having zero practicing gynecologists [14].